Denys Damiaan, Fluitman Sjoerd, Kavelaars Annemieke, Heijnen Cobi, Westenberg Herman G M
Department of Psychiatry, UMC, Rudolf Magnus Institute of Neuroscience, B.01.206, P.O. Box 85500, 3508 GA Utrecht, The Netherlands.
Psychoneuroendocrinology. 2006 Apr;31(3):355-60. doi: 10.1016/j.psyneuen.2005.08.016. Epub 2005 Oct 24.
Obsessive-compulsive disorder (OCD) has been associated with an altered activity of the immune system. This study was carried out to investigate whether treatment with paroxetine and venlafaxine modifies the immune function in OCD and whether this modification is related to treatment outcome.
Ex vivo production of TNF-alpha, IL-4, IL-6, IL-10, and IFN-gamma in whole blood cultures, and NK-cell activity and peripheral blood NK-cell-, monocytes-, T-cell-, and B-cell- percentages were measured in 42 outpatients with OCD who participated in a 12-week, double-blind SRI trial.
Paroxetine and venlafaxine treatment did not affect immune parameters and clinical response was not directly related to altered activity of the immune system. Responders, defined as having a >or=25% decrease on the Y-BOCS, differed from non-responders with regard to the change of TNF-alpha values.
The present results suggest that paroxetine and venlafaxine do not affect immune parameters and that clinical response is not related to altered activity of the immune system in OCD. Nonetheless, our data yielded interesting preliminary results that warrant further discussion and investigation.
强迫症(OCD)与免疫系统活动改变有关。本研究旨在调查帕罗西汀和文拉法辛治疗是否会改变强迫症患者的免疫功能,以及这种改变是否与治疗结果相关。
在42名参与为期12周双盲SRI试验的强迫症门诊患者中,检测全血培养物中TNF-α、IL-4、IL-6、IL-10和IFN-γ的体外产生,以及NK细胞活性和外周血NK细胞、单核细胞、T细胞和B细胞百分比。
帕罗西汀和文拉法辛治疗不影响免疫参数,临床反应与免疫系统活动改变无直接关系。以Y-BOCS评分降低≥25%定义的应答者与无应答者在TNF-α值变化方面存在差异。
目前的结果表明,帕罗西汀和文拉法辛不影响免疫参数,强迫症的临床反应与免疫系统活动改变无关。尽管如此,我们的数据产生了有趣的初步结果,值得进一步讨论和研究。